AzTrials
AzTrials

Anxiety DisordersNCT05747131

Emotion Detectives In-Out: Feasibility and Efficacy of a Blended Version of the Unified Protocol for Children

A study testing Emotion Detectives In-Out and Coping Cat in people with Anxiety Disorders, run by University of Coimbra at 2 sites in Portugal.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to test the efficacy of a blended format (i.e., a combination of face-to-face and online sessions into one integrated treatment protocol) of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Children (UP-C) in a sample of children aged between 7 and 12… Read more about this study

Who is it for?
Ages 7 to 12 years
Conditions the study is for
Anxiety Disorders
What is being tested?
Emotion Detectives In-Out and Coping Cat
Could I receive a placebo?
No, everyone receives an active treatment
How many people
180 participants
Where
2 sitesPortugal
Study dates
Sep 2023to Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • The child is aged between 7 and 12 years;
  • The child has a primary diagnosis of an anxiety disorder or clinically significant anxiety symptoms;
  • Both the child and the parent are able to speak, read and understand Portuguese;
  • Both the child and the parent have Internet access.

Who cannot join

  • Diagnosis of a psychotic disorder, bipolar disorder, intellectual disability or autism spectrum disorder;
  • Severe current suicidal ideation;
  • The child is not on a stable dose of a psychotropic or other type of medication for at least 1 month prior to T0 assessment;
  • The child has previously received CBT with exposure techniques.

Trial locations and contacts

2 sites in 1 country.

Helena Moreira, PhD contact

00351918811714

helena.tcmoreira@gmail.com

Ana Isabel Pereira, PhD contact

aipereira@psicologia.ulisboa.pt

Portugal2 sites
  • Faculty of Psychology and Educational Sciences

    Coimbra, 3000-115

  • Faculty of Psychology, University of Lisbon

    Lisbon

    Ana Isabel Pereira, PhD

    Ana Isabel Pereira, PhD

Other trials in Portugal

About this study

Official title: Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Children: A Multicenter Study to Assess the Acceptability, Feasibility and Efficacy of a Blended Format of the Program in Portugal

The goal of this clinical trial is to test the efficacy of a blended format (i.e., a combination of face-to-face and online sessions into one integrated treatment protocol) of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Children (UP-C) in a sample of children aged between 7 and 12 years with a primary diagnosis of an anxiety disorder or with clinically significant levels of anxiety.

The main questions it aims to answer are:

Read more
  • Is the proposed intervention (named Emotion Detectives In-Out) feasible and acceptable among Portuguese children with anxiety disorders and their parents?
  • Is the Emotion Detectives In-Out intervention as effective as an evidence-based intervention for children's anxiety disorders in reducing anxiety symptomatology and changing secondary outcomes?
  • What are the key predictors of adherence to the Emotion Detectives In-Out intervention?
  • What are the key predictors of treatment outcomes?

Participants (children and one parent/legal representative) will:

  • Participate in an initial interview with a clinical psychologist, who will assess if children and parents meet eligibility criteria.
  • Complete an assessment protocol before, during, and after the intervention, as well as three months later.
  • Be randomly assigned to one of the two conditions: experimental (Emotion Detectives In-Out) or active control (Coping Cat).
  • Participate in one of the two psychological interventions. Researchers will compare the experimental and control groups to see if the Emotion Detectives In-Out intervention is equally efficacious as the Coping Cat intervention.
Read the detailed description

Childhood emotional disorders, particularly anxiety disorders, are an important public health concern due to their high and increasing prevalence, impact on children's functioning in multiple domains (e.g., family, academic, social), and long-term consequences. However, there is a significant gap between their needs and access to mental healthcare, with most children lacking access to evidence-based treatments (EBT). Several factors can contribute to a lack of adequate mental health care for children, including an insufficient number of trained clinicians, the difficulty of effectively disseminating the multitude of disorder-specific EBTs for emotional disorders to clinicians, and other barriers to face-to-face treatment. An Internet-based intervention can be an effective solution to overcome these difficulties. This project aims to develop and test the efficacy of a blended intervention of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Children (UP-C).

The UP-C is a cognitive-behavioral therapy (CBT) that takes a transdiagnostic approach to treating multiple emotional disorders simultaneously by addressing shared mechanisms underlying these disorders and employing a common set of EBT strategies (e.g., exposure, mindfulness). It is a child-friendly extension of the adult UP that delivers the UP core components in an interactive and child-friendly group format with extensive parent involvement. It has 15 weekly sessions for children and 15 weekly sessions for parents with an approximate duration of 90 minutes each. With a blended approach the researchers aim to improve the delivery of UP-C, by retaining the benefits of face-to-face and online therapy, while mitigating their limitations. This new version is expected to reduce costs of the therapy for families and institutions while also increasing compliance, motivation, uptake of treatment principles, and facilitating generalization of the application of core treatment components.

The blended version of the UP-C, named "Emotion Detectives In-Out" consists of 15 weekly sessions with the children (9 face-to-face group sessions, 4 online self-guided sessions and 2 videoconference sessions). The groups will consist of about 5 to 7 children. Face-to-face sessions have an expected duration of 90 minutes and will be implemented by clinical psychologists with specific training in the program. The online sessions were developed by the research team and are completely self-guided. These sessions last approximately 45 minutes. Parents will be asked to participate in 2 face-to-face sessions, 4 videoconference sessions and 10 self-guided online sessions.

Being tested
Emotion Detectives In-Out, Coping Cat
Keywords
Unified Protocol, Children, Blended therapy, Parents
Medical subject headings
Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Emotion Detectives In-OutBehavioural

    Emotion Detectives In-Out is a blended cognitive-behavioral intervention for children with emotional disorders aged between 7 to 12 years and their parents. It contains group sessions, online self-guided sessions and videoconference sessions. The groups will consist of about 5 to 7 children. Face-to-face sessions have an expected duration of 90 minutes and will be implemented by clinical psychologists with specific training in the program. The online sessions were developed by the research team and are completely self-guided. These sessions last approximately 45 minutes. Parents will be asked to participate in 2 face-to-face sessions, 4 videoconference sessions and 10 self-guided online sessions. It is a transdiagnostic and emotion-focused manualized cognitive-behavioral therapy designed to help children reduce the intensity and frequency of strong and aversive emotional experiences and to help parents reduce parental emotional behaviors.

  • Coping CatBehavioural

    Coping Cat is a cognitive behavioral therapy for children with anxiety aged between 7 to 13 years. Coping Cat consists of 16 weekly group sessions with the children (5 to 7 children per group) and 2 sessions with the parents. Face-to-face sessions have an expected duration of 90 minutes and will be implemented by clinical psychologists.

Study groups in NCT05747131
Study groupRoleWhat they receive
Emotion Detectives In-OutExperimentalEmotion Detectives In-Out consists of 15 weekly sessions with the children (9 face-to-face group sessions, 4 online sessions and 2 videoconference sessions).
Receives: Behavioral: Emotion Detectives In-Out
Coping CatActive comparatorCoping Cat consists of 16 weekly group sessions with the children (5 to 7 children per group) and 2 sessions with the parents.
Receives: Behavioral: Coping Cat

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in anxiety symptoms as measured by the Revised Children's Anxiety and Depression Scale (RCADS).

    The Revised Children's Anxiety and Depression Scale is a 47 item self-report questionnaire that measures symptoms of depression and anxiety in children and adolescents aged 8 - 18. It has 6 subscales: separation anxiety disorder, social phobia, generalized anxiety disorder, panic disorder, obsessive compulsive disorder, and low mood (major depressive disorder). It yields a Total Anxiety Scale (the sum of the 5 anxiety subscales) and a Total Anxiety \& Depression Scale (sum of all 6 subscales). The Total Anxiety Scale ranges from 0 to 111, and the Total Anxiety \& Depression scale ranges from 0 to 141, with higher scores indicating increased symptom severity.

    Measured: Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up]

  2. Change in anxiety symptoms as measured by the Revised Children's Anxiety and Depression Scale - Parent version (RCADS-P).

    The Revised Child Anxiety and Depression Scale - Parent Version (RCADS-P) is a 47 item parent-reported questionnaire that measures symptoms of depression and anxiety in children and adolescents aged 8 - 18. It has 6 subscales: separation anxiety disorder, social phobia, generalized anxiety disorder, panic disorder, obsessive compulsive disorder, and low mood (major depressive disorder). It yields a Total Anxiety Scale (the sum of the 5 anxiety subscales) and a Total Anxiety \& Depression Scale (sum of all 6 subscales). The Total Anxiety Scale ranges from 0 to 111, and the Total Anxiety \& Depression scale ranges from 0 to 141, with higher scores indicating increased symptom severity.

    Measured: Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up

  3. Change in anxiety symptoms as measured by the Clinician Global Impression - Improvement scale (CGC-I).

    Higher scores indicate increased symptom worsening.

    Measured: within 1 week post-treatment

  4. Change in severity of anxiety symptoms as measured by the Clinician Global Impression - Severity scale (CGC-S).

    The Clinician Global Impression - Severity scale is a one-item measure assessing the clinician's perception of the severity of the patient's symptoms, with scores ranging from 1 (not at all ill) to 7 (extremely ill). Higher scores indicate increased symptom severity.

    Measured: Baseline, within 1 week post-treatment

Secondary outcomes (15)
  1. Change in the interference of anxiety in child's life, as measured by the Child Anxiety Life Interference Scale - Self-Report (CALIS-C)

    The Child Anxiety Life Interference Scale - Self-Report consists of a 9-item scale administered to children. Items are rated on a 5-point Likert scale (0 = not at all to 4 = a great deal). The total score ranges from 0 to 36, with higher scores indicating greater interference of anxiety symptoms in children's life.

    Measured: Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up

  2. Change in the interference of anxiety in child's life, as measured by the Child Anxiety Life Interference Scale - Parent's Report (CALIS-P)

    The Child Anxiety Life Interference Scale - Parent's Report consists of two 9-item scales (Child Interference Subscale and Family Interference Subscale) administered to parents. Items are rated on a 5-point Likert scale (0 = not at all to 4 = a great deal). The total scores of the Child Interference Subscale and of the Family Interference Subscale range from 0 to 36, with higher scores indicating greater interference of anxiety symptoms in the lives of children and families, respectively.

    Measured: Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up

  3. Change in children's behavioral avoidance, as measured by the Child Avoidance Measure Self-Report (CAMS)

    The Child Avoidance Measure Self-Report is an 8-item self-report measure that assesses children's behavioral avoidance when faced with stimuli that elicit anxiety, fear, or worry, from the child's perspective. Items are rated on a 4-point Likert scale (0 = Almost Never to 3 = Almost Always). The total score ranges from 0 to 24, with higher scores indicating higher behavioral avoidance.

    Measured: Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up

  4. Change in children's behavioral avoidance, as measured by the Child Avoidance Measure Parent-Report (CAMP)

    The Child Avoidance Measure Parent-Report is an 8-item measure that assesses children's behavioral avoidance when faced with stimuli that elicit anxiety, fear, or worry, from the parents' perspective. Items are rated on a 4-point Likert scale (0 = Never, almost never, or not an issue to 3 = Almost Always). The total score ranges from 0 to 24, with higher scores indicating higher behavioral avoidance.

    Measured: Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up

  5. Change in children's positive and negative affect, as measured by the Positive and Negative Affect Schedule for Children - Short Version (PANAS-C-SF)

    The Positive and Negative Affect Schedule for Children - Short Version has 10 items and is composed by two subscales (Positive Affect and Negative Affect). Items are answered in a 5-item Likert scale that ranges from 1 (Very slightly or not at all) to 5 (Extremely). Both subscales can range from 5 to 25, with higher scores on Positive Affect indicating greater intensity of positive emotions, and higher scores on Negative Affect indicating greater intensity of negative emotions.

    Measured: Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up

  6. Change in children's anxiety sensitivity, as measured by the Children's Anxiety Sensitivity Inventory-Revised (CASI-R).

    The Children's Anxiety Sensitivity Inventory-Revised is a 31 item self-report scale that measures children's anxiety sensitivity across four domains: fear of cardiovascular symptoms, fear of publicly observable anxiety reactions, fear of cognitive dyscontrol and fear of respiratory symptoms. Items are answered in a 3-item Likert scale that ranges from 0 (Not true) to 3 (Very true). A total anxiety sensitivity score can be obtained by summing across all items and ranges from 0 to 93, with higher scores indicating higher anxiety sensitivity.

    Measured: Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up

  7. Change in children's difficulties in emotion expression, as measured by the Emotional Expression Scale for Children (EESC)

    The Emotional Expression Scale for Children is a 16 item self-report questionnaire that assesses children's difficulties in emotion expression (i.e., poor emotion awareness and reluctance to express emotions). Items are answered on a 5-point Likert-type scale that ranges from 1 (Not at All True) to 5 (Extremely true). The total score ranges from 16 to 80, with higher scores indicating greater difficulty in expressing emotions.

    Measured: Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up

  8. Change in children's negative cognitive errors, as measured by the Children's Negative Cognitive Error Questionnaire (CNCEQ)

    The Children's Negative Cognitive Error Questionnaire is a 24 item self-report questionnaire that assesses four types of cognitive errors: catastrophizing, overgeneralizing, personalizing, and selective abstraction. Items are answered on a 5-point scale that ranges from 1 (Nothing like I would think) to 5 (Exactly what I would think). A total cognitive distortion score can be obtained, ranging from 24 to 120. Higher scores indicate more distorted cognitive processes.

    Measured: Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up

  9. Change in children's quality of life, as measured by the KIDSCREEN-10 Index (Parent Report)

    The KIDSCREEN-10 Index (parent report) assesses children's overall levels of quality of life (physical, mental and social) as reported by their parents. Items are answered on a 5-point Likert scale ranging from 1 (never/not at all) to 5 (always/extremely). The sum of all items provides a global index of quality of life. The standardized scores ranges from 0 to 100, with higher results suggesting a better quality of life.

    Measured: Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up

  10. Change in parental overprotection, as measured by the Parental Anxiety and Overprotection Scale (PAOS)

    The Parental Anxiety and Overprotection Scale assesses parents' overprotection behaviors and other behaviors that aim to encourage children to cope with and face situations that cause them anxiety. The parental overprotection subscale has 7 items and the support of children's coping behaviors subscale has 3 items, which are both rated on a 5-point Likert scale ranging from 0 (nothing) to 4 (a lot). The total score of the overprotection subscale can range from 0 to 28 and total score of the support of children's coping behaviors subscale can range from 0 to 12, with higher scores indicating higher levels of parental overprotection and higher levels of parental supportive behaviors, respectively.

    Measured: Baseline, within 1 week post-treatment, 3 months follow-up

  11. Change in parental criticism as measured by the Egna Minnen Beträffande Uppfostran Scale (EMBU-P)

    The Rejection subscale of Egna Minnen Beträffande Uppfostran Scale assesses parents' levels of criticism towards their child. This subscale has 17 items answered on a 4-point Likert scale that ranges from 1 (No, never) to 4 (Yes, always). The total rejection score can range from 17 to 68, with higher scores suggesting higher levels of rejection and criticism.

    Measured: Baseline, within 1 week post-treatment, 3 months follow-up

  12. Change in parental modeling of intense emotions, as measured by the Parent Emotion Regulation Scale (PERS)

    The Parents' Lack of Emotional Control subscale of the Parent Emotion Regulation Scale assesses parents' lack of ability to modulate their own negative emotions in the presence of the child. This subscale has 4 items answered on a 5-point Likert scale that ranges from 0 (never or almost never) to 4 (always or almost always). The total score can range from 0 to 4, with higher scores indicating a higher level of negative emotion modeling.

    Measured: Baseline, within 1 week post-treatment, 3 months follow-up

  13. Change in parental inconsistency, as measured by the Parenting Inconsistency Scale

    Parenting Inconsistency Scale has 9 items answered on a 5-point Likert scale that ranges from 1 (does not describes me at all) to 5 (describes me completely). The total score can range from 1 to 5, with higher scores indicating a higher level of parental inconsistency.

    Measured: Baseline, within 1 week post-treatment, 3 months follow-up

  14. Change in parental depressive symptoms, as measured by the Patient Health Questionnaire-9 (PHQ-9).

    The Patient Health Questionnaire-9 is a brief self-report measure used to monitor the severity of depression symptoms. The scale has 9 items answered on a 4-point Likert scale that ranges from 0 (not at all) to 3 (nearly every day). The total score can range from 0 to 27, with higher scores indicating higher levels of depression severity.

    Measured: Baseline, within 1 week post-treatment, 3 months follow-up

  15. Change in parental anxiety symptoms, as measured by the General Anxiety Disorder-7 (GAD-7).

    The General Anxiety Disorder-7 is a brief self-report measure used to monitor the severity of anxiety symptoms. The scale has 7 items answered on a 4-point Likert scale that ranges from 0 (not at all) to 3 (nearly every day). The total score can range from 0 to 21, with higher scores indicating higher levels of anxiety severity.

    Measured: Baseline, within 1 week post-treatment, 3 months follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Feb 2023
  2. Study startSep 2023 (estimated)
  3. Primary completionJul 2024 (estimated)
  4. Study completionDec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
180 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05747131
Sponsor's protocol ID
PTDC/PSI-GER/0689/2020
Status last verified
May 2023
First submitted
7 Feb 2023
Last updated
12 May 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Moreira H, Skvarc D, Gomes-Pereira B, Albuquerque A, Gois AC, Fonseca A, Pereira AM, Caiado B, Paulino B, Santos C, Ehrenreich-May J, Canavarro MC, Saraiva M, Vicente VN, Pereira AI. Study protocol for a randomized controlled trial testing the efficacy of Emotion Detectives In-Out: a blended version of the unified protocol for transdiagnostic treatment of emotional disorders in Portuguese children. BMC Psychol. 2024 Feb 7;12(1):63. doi: 10.1186/s40359-024-01532-z.

    PubMed 38326847

Questions about this trial

What is this clinical trial studying?

A study testing Emotion Detectives In-Out and Coping Cat in people with Anxiety Disorders, run by University of Coimbra at 2 sites in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Helena Moreira, PhD (00351918811714, helena.tcmoreira@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in anxiety symptoms as measured by the Revised Children's Anxiety and Depression Scale (RCADS). (time frame: Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up]). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05747131, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in